4th Quarter - Report — QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED (2020)

Firm

QUEST DIAGNOSTICS INCORPORATED

Client

QUEST DIAGNOSTICS INCORPORATED

Income

—

Expenses

$220,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting Federal policy relating to implementation of anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Public Law 115-271 H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests The Public Readiness and Emergency Preparedness Act (PREP Act) and COVID-19 liability protection for frontline health care providers, including CLIA-licensed laboratories and their personnel H.R. 8496, the SPEEDY COVID-19 Tests Act, relating to varying Medicare reimbursement for COVID-19 tests based on result delivery time Section 307 of H.R. 8406, the Heroes Act, provisions relating to coverage of COVID-19 testing H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260), and provisions related to clinical laboratory testing for COVID-19, and Medicare reimbursement for pathology services

Lobbyist	Covered position, as disclosed
SHERRY HARPER WIDICUS	—

Contacted: Centers For Disease Control & Prevention (CDC); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6201 (116th), H.R. 8406 (116th), H.R. 6102 (116th), S. 3404 (116th), H.R. 748 (116th), H.R. 133 (116th), H.R. 8496 (116th)

Medicare/Medicaid MMM

Monitor implementation of H.R. 1865, Further Consolidated Appropriations Act, 2020, (Public Law 116-94) and provisions related to policies regarding data collection from laboratories under the Protecting Access to Medicare Act (PAMA) S. 2246, Allergy Testing Access Act of 2019, and H.R. 2009, the Removing Barriers to Allergy Diagnostic Tests Act, and provisions relating to Medicare and Medicaid coverage of allergy diagnostic tests H.R. 1765, the Donald Payne Sr. Colorectal Cancer Detection Act H.R. 8702/S. 5007, the Holding Providers Harmless from Medicare Cuts During COVID-19 Act

Lobbyist	Covered position, as disclosed
SHERRY HARPER WIDICUS	—

Contacted: Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Bills named: S. 2246 (116th), H.R. 8702 (116th), S. 5007 (116th), H.R. 2009 (116th), H.R. 1865 (116th), H.R. 1765 (116th)

Homeland Security HOM

National Interest Waiver program for essential workers entering the U.S

Lobbyist	Covered position, as disclosed
SHERRY HARPER WIDICUS	—

Contacted: SENATE; Homeland Security, Dept of (DHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.